Lotus Announces Closing of Previously Announced Transactions
Lotus Announces Closing of Previously Announced Transactions
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2024) - Lotus Ventures Inc. (CSE: J) ("Lotus" or the "Company") announces today that it has closed the previously announced transaction (the "Transaction") contemplated by the Company's proposal to its creditors, as amended (the "Proposal"), and the Company's subscription agreement dated May 3, 2024 with 5008679 Ontario Limited (the Purchaser"), as amended and restated on June 4, 2024 and further amended on July 15, 2024 (the "Agreement"). The Transaction was completed in accordance with the terms of the Agreement and the provisions of a reverse-vesting order granted by the Supreme Court of British Columbia In Bankruptcy and Insolvency on June 14, 2024 (the "RVO").
温哥华,不列颠哥伦比亚州-(新闻稿-2024年8月19日)-莲花Ventures Inc. (CSE: J) ("莲花"或"公司")今天宣布,根据公司向债权人提出的提案("提案")及于2024年5月3日与5008679 Ontario Limited ("购买方")签署的认购协议,并经2024年6月4日进一步修改及于2024年7月15日再度修改的协议("协议"),以及加拿大不列颠哥伦比亚省最高法院破产与破产申请颁发的反向完全套期权令("RVO"),该公司已完成先前宣布的交易("交易")。该交易已根据协议条款及RVO规定完成。
As part of the completion of the Transaction, the Company has issued to the Purchaser 1,000 common shares of the Company (the "Subscribed Shares") for an aggregate, all-inclusive purchase price of $2,538,398.00 and all of the previously issued and outstanding securities of the Company (other than the Subscribed Shares) have been cancelled without consideration. The Purchaser, located at 1662 Valley Close, Burlington, Ontario, L7P 4W4, is now the sole securityholder of the Company. Prior to the Transaction, the Purchaser held, directly or indirectly, 7,003,733 common shares of the Company, representing 6% of the issued and outstanding common shares of the Company.
作为交易完成的一部分,公司发行1,000股公司普通股("认购股"),以总购买价2,538,398.00美元出售,并取消了公司全部已发行和未偿还的证券(除认购股以外的证券)。位于安大略省伯灵顿市1662 Valley Close的购买方现已成为公司唯一的证券持有人。在交易之前,购买方直接或间接持有公司的7,003,733股普通股,相当于已发行并未流通的普通股的6%。
Lotus is expected to be delisted from the CSE effective at the close of trading on August 20, 2024, and is expected to be concurrently delisted from the OTC Markets. Lotus also expects to make an application to seek full revocation of the failure-to-file cease trade order issued on April 4, 2024, and to cease to be a reporting issuer in each of Alberta, British Columbia, and Ontario.
预计莲花股份将在2024年8月20日交易结束时从CSE交易所撤销上市,并同时从OTC Markets撤销上市。莲花还预计将申请寻求关于2024年4月4日发出的未能提交报告所致止交令的全面撤销,并停止成为阿尔伯塔、不列颠哥伦比亚和安大略每个地区的报告发行人。
Further information regarding the Proposal and the Agreement, including copies thereof, can be accessed through the website hosted by MNP Ltd., in its capacity of proposal trustee of Lotus in the Proposal proceedings, at: Lotus Ventures Inc | MNP LTD (mnpdebt.ca).
有关建议和协议的进一步信息,包括副本,可以访问由MNP Ltd.托管的网站,作为建议程序中Lotus的建议受托管理人,在此处:Lotus Ventures Inc | MNP LTD(mnpdebt.ca)。
This disclosure is also issued pursuant to Multilateral Instrument 62-104 - Take-Over Bids and Issuer Bids, which requires an early warning report to be filed containing additional information with respect to the foregoing matters. A copy of the early warning report will be made available on SEDAR+ under Lotus' profile at . To obtain a copy of the early warning report, or further information, please contact Albert Duwyn, President of Lotus, at 416-460-7058.
本公告还根据多边协议62-104-收购要约和发行人要约要求发布,其中要求提交一份早期警告报告,其中包含有关上述事项的其他信息。早期警告报告的副本将在卫星+ Lotus'高级档案下提供。要获取早期警告报告或进一步信息,请联系莲花公司总裁Albert Duwyn,电话416-460-7058。
About Lotus Ventures Inc.
Lotus Ventures Inc. is a BC based licensed cannabis producer. Lotus grows premium cannabis which is carried in retail locations across BC and Ontario.
关于莲花企业股份有限公司。
莲花企业股份有限公司是总部位于BC的持牌大麻生产商。莲花种植优质大麻,其产品销售于BC和安大略省的零售店。
Forward-Looking Information:
This document includes certain statements that are not descriptions of historical facts but are forward-looking statements. Such statements include, among others, those concerning the delisting of Lotus from the CSE and OTC Markets and the timing thereof, receipt of a revocation order relating to the applicable cease trade order of Lotus, Lotus ceasing to be a reporting issuer in Alberta, BC and Ontario, our expected financial performance and strategic and operational plans, our future operating results, our expectations regarding the market for medical and recreational cannabis products, our expectations regarding the continued growth of the medical and recreational cannabis market, as well as all assumptions, expectations, predictions, intentions, or beliefs about future events. Users are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause our actual results to differ materially from those anticipated, expressed or implied in the forward-looking statements. These risks and uncertainties have not been documented or mentioned in this document nor other communications made by the company. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.
前瞻性信息:
本文件包括某些不是历史事实描述的陈述,而是前瞻性陈述。这些陈述包括但不限于有关莲花从CSE和OTC Markets中的退市以及时间,关于有关莲花的适用停止交易令吊销令的撤销要求,特定风险因素和不确定性的描述,我们预期的财务表现和策略性、操作性计划,我们的未来经营业绩,我们关于医疗和娱乐大麻产品市场的预期,我们关于医疗和娱乐大麻市场持续增长的预期,以及所有假设、期望、预测、意图或对未来事件的信念。用户应注意,任何此类前瞻性陈述均不能保证未来业绩,一些风险和不确定性可能会使我们的实际结果与前瞻性陈述所预测的结果存在实质性差异。本文档未记录或提及这些风险和不确定性。"相信"、"预计"、"期望"、"项目"、"目标"、"乐观"、"打算"、"瞄准"、"将"或类似的表达旨在识别前瞻性陈述。除历史事实陈述外,所有陈述均可能被视为前瞻性陈述。公司不承担任何义务,并不打算更新任何前瞻性陈述,除非法律另有要求。
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
加拿大证券交易所不对本公告的充分性或准确性负责。